These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 7524715)
1. Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies. Liautard J; Gaillard JP; Mani JC; Montero-Julian F; Duperray C; Lu ZY; Jourdan M; Klein B; Brailly H; Brochier J Eur Cytokine Netw; 1994; 5(3):293-300. PubMed ID: 7524715 [TBL] [Abstract][Full Text] [Related]
2. IL-6-induced changes in synthesis of alpha 1-acid glycoprotein in human hepatoma Hep3B cells are distinctively regulated by monoclonal antibodies directed against different epitopes of IL-6 receptor (gp80). Daveau M; Liautard J; Gaillard JP; Hiron M; Brochier J; Lebreton JP Eur Cytokine Netw; 1994; 5(6):601-8. PubMed ID: 7537107 [TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor. Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331 [TBL] [Abstract][Full Text] [Related]
4. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6. Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772 [TBL] [Abstract][Full Text] [Related]
6. Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors. Brochier J; Liautard J; Jacquet C; Gaillard JP; Klein B Eur J Immunol; 2001 Jan; 31(1):259-64. PubMed ID: 11265642 [TBL] [Abstract][Full Text] [Related]
7. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. Hirata Y; Taga T; Hibi M; Nakano N; Hirano T; Kishimoto T J Immunol; 1989 Nov; 143(9):2900-6. PubMed ID: 2681418 [TBL] [Abstract][Full Text] [Related]
8. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma. Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel antigenic structure of the human receptor for interleukin-6 involved in the interaction with the glycoprotein 130 chain. Gaillard JP; Liautard J; Mani JC; Fernandez Suarez JM; Klein B; Brochier J Immunology; 1996 Sep; 89(1):135-41. PubMed ID: 8911151 [TBL] [Abstract][Full Text] [Related]
10. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125 [TBL] [Abstract][Full Text] [Related]
11. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells. Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270 [TBL] [Abstract][Full Text] [Related]
13. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130). Geisterfer M; Richards CD; Gauldie J Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365 [TBL] [Abstract][Full Text] [Related]
14. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA. Oh JW; Revel M; Chebath J Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669 [TBL] [Abstract][Full Text] [Related]
15. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components. Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410 [TBL] [Abstract][Full Text] [Related]
16. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains. Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587 [TBL] [Abstract][Full Text] [Related]
17. A monoclonal anti-human IL-6 receptor antibody inhibits the proliferation of human myeloma cells. Huang YW; Vitetta ES Hybridoma; 1993 Oct; 12(5):621-30. PubMed ID: 8300137 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Pallua N; Low JF; von Heimburg D Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624 [TBL] [Abstract][Full Text] [Related]
19. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315 [TBL] [Abstract][Full Text] [Related]
20. Activation of the gp130 signaling pathway by monoclonal antibodies directed against the gp130 molecule. Autissier P; Liautard J; Brochier J; Gaillard JP Eur J Immunol; 1997 Mar; 27(3):794-7. PubMed ID: 9079824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]